Kestra Medical Technologies, Ltd.
KMTS
$27.90
-$0.45-1.59%
NASDAQ
| 04/30/2026 | 01/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 16.64% | 8.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.64% | 8.81% | |||
| Cost of Revenue | 11.25% | 4.53% | |||
| Gross Profit | 21.51% | 12.97% | |||
| SG&A Expenses | 15.67% | 11.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.61% | 9.20% | |||
| Operating Income | -13.17% | -9.48% | |||
| Income Before Tax | -13.22% | -4.21% | |||
| Income Tax Expenses | 448.57% | 2.94% | |||
| Earnings from Continuing Operations | -13.67% | -4.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -13.67% | -4.21% | |||
| EBIT | -13.17% | -9.48% | |||
| EBITDA | -12.92% | -11.57% | |||
| EPS Basic | -9.06% | 4.12% | |||
| Normalized Basic EPS | -8.61% | 4.12% | |||
| EPS Diluted | -9.06% | 4.12% | |||
| Normalized Diluted EPS | -8.61% | 4.12% | |||
| Average Basic Shares Outstanding | 4.23% | 8.70% | |||
| Average Diluted Shares Outstanding | 4.23% | 8.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||